Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,696 | -29,154 | -16,486 | -7,324 | -27,401 |
| Depreciation Amortization | 26 | 19 | 13 | 6 | 43 |
| Accounts payable and accrued liabilities | 1,082 | -416 | -805 | N/A | -62 |
| Other Working Capital | 8,728 | 9,470 | -4,051 | -1,032 | 1,543 |
| Other Operating Activity | 96 | 1,232 | 1,162 | -28 | 642 |
| Operating Cash Flow | $-28,764 | $-18,848 | $-20,169 | $-8,377 | $-25,235 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15 | -15 | N/A | N/A | -18 |
| Investing Cash Flow | $-15 | $-15 | $N/A | $N/A | $-18 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 367 |
| Common Stock Issued | 75,847 | 59,843 | 24,627 | 11,375 | 24,763 |
| Financing Cash Flow | $75,847 | $59,843 | $24,627 | $11,375 | $25,131 |
| Exchange Rate Effect | -64 | -79 | -16 | -7 | 11 |
| Beginning Cash Position | 4,670 | 4,670 | 4,670 | 4,670 | 4,780 |
| End Cash Position | 51,674 | 45,571 | 9,112 | 7,660 | 4,670 |
| Net Cash Flow | $47,005 | $40,901 | $4,442 | $2,991 | $-111 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,764 | -18,848 | -20,169 | -8,377 | -25,235 |
| Capital Expenditure | -15 | -15 | N/A | N/A | -18 |
| Free Cash Flow | -28,779 | -18,863 | -20,169 | -8,377 | -25,253 |